Alzheimer’s and other neurodegenerative diseases have been found to involve inflammation and oxidative stress (damage from free radicals) and it has been hoped that use of anti-inflammatory or antioxidant agents might reduce the development or severity of Alzheimer’s. Studies have been done with a variety of antioxidants such as Vitamin E,C, Carotenoids, Lipoic acid and Coenzyme Q10.
Advances in medical science and public health have steadily prolonged life expectancy in most of the developed world, but the prospect of an exploding population of elderly people has brought with it a host of new challenges. None of these is more formidable than the looming epidemic of Alzheimer’s. The personal, economic and social costs could be staggering, and governments and healthcare specialists are struggling to fashion a response.
Diagnosing Alzheimer’s is usually the purview of neurologists and there are brain scans and other tests that are being developed to help with early diagnosis. There are also screening tests of cognitive function and formal neuropsychological testing to fully document mental capacity and dysfunction.